Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maaike Heslinga
Observed names:
M Heslinga,
M. Heslinga,
MAAIKE HESLINGA
Institution:
Reade
Observed institutions:
Reade,
Spaarne Ziekenhuis,
Amsterdam University Medical Centers,
Amsterdam Cardiovascular Sciences,
Vrije Universiteit Amsterdam,
Amsterdam UMC Location Vrije Universiteit Amsterdam
show all 6
ORCID:
0000-0002-3283-3969
Observed ORCID:
0000-0002-3283-3969
OpenAlex ID:
A5007229647
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
2016
·
R Agca
, S C Heslinga
, et al.
·
Annals of the Rheumatic Diseases
·
1,392
PDF
Cardiovascular comorbidity in rheumatic diseases
2015
·
Michael T. Nurmohamed
, Maaike Heslinga
, et al.
·
Nature Reviews Rheumatology
·
331
Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus
2016
·
Michel W. P. Tsang-A-Sjoe
, Irene E. M. Bultink
, et al.
·
Rheumatology
·
180
PDF
Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review
2019
·
Daisy Vedder
, Wendy Walrabenstein
, et al.
·
Nutrients
·
63
PDF
The relationship between remission and health-related quality of life in a cohort of SLE patients
2018
·
Michel W P Tsang-A-Sjoe
, Irene E M Bultink
, et al.
·
Rheumatology
·
52
Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project
2017
·
Inge A. M. van den Oever
, Maaike Heslinga
, et al.
·
Rheumatology
·
41
Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme
2019
·
M Heslinga
, IAM Van Den Oever
, et al.
·
Scandinavian Journal of Rheumatology
·
25
The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis
2017
·
Rabia Agca
, Maaike Heslinga
, et al.
·
The Journal of Rheumatology
·
20
PDF
Amplified prevalence and incidence of cardiovascular disease in patients with inflammatory arthritis and coexistent autoimmune disorders
2019
·
Maaike Heslinga
, Mark M J Nielen
, et al.
·
Rheumatology
·
14
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
2022
·
I. A. P. Swart
, I. M. Visman
, et al.
·
Clinical Rheumatology
·
12
PDF
NT-proBNP and sRAGE levels in early rheumatoid arthritis
2022
·
M Heslinga
, C Teunissen
, et al.
·
Scandinavian Journal of Rheumatology
·
7
PDF
Coexistent subclinical hypothyroidism is associated with an increased risk of new cardiovascular events in rheumatoid arthritis: an explorative study
2021
·
R Agca
, M Heslinga
, et al.
·
Scandinavian Journal of Rheumatology
·
6
PDF
Cardiometabolic Effects of Apremilast in Patients With Psoriatic Arthritis: A Prospective Cohort Study
2025
·
Romy Hansildaar
, Eva H. van Geel
, et al.
·
The Journal of Rheumatology
·
4
Favorable effects on the hemostatic system in ankylosing spondylitis patients treated with golimumab
2020
·
Ingrid Visman
, Maaike Heslinga
, et al.
·
Joint Bone Spine
·
3
Change in cardiovascular risk after initiation of anti-rheumatic treatment in early rheumatoid arthritis.
2019
·
Samina A Turk
, Maaike Heslinga
, et al.
·
PubMed
·
3
Cardiovascular risk management in gout patients: do patients benefit from screening in secondary care?
2022
·
Daisy Vedder
, Maaike Heslinga
, et al.
·
Clinical and Experimental Rheumatology
·
2
Cardiovascular Disease Reduction in Rheumatoid Arthritis by Statins: The Final Evidence?
2016
·
MAAIKE HESLINGA
, MICHAEL T. NURMOHAMED
·
The Journal of Rheumatology
·
2
PDF
Ab0397 No Clinically Relevant Changes in Coagulation Activation Between Patients Initiating Tnf-blockers Versus Jak-inhibitors
2023
·
R. Hansildaar
, R. Raadsen
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Fri0725-hpr a Tailor-made Exercise Program Designed for Improving Cardiorespiratory Fitness in Patients With Rheumatoid Arthritis and Increased Cardiovascular Risk
2019
·
Joëlle van den Hoek
, Martin van der Esch
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
SAT0114 Poor cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk management program
2017
·
M Heslinga
, I van den Oever
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Cardiac Diseases in Rheumatoid Arthritis
2017
·
R. Agca
, M. Heslinga
, et al.
·
Technical report
·
1
SAT0284 Both Prolonged Remission and Lupus Low Disease Activity State Are Associated with Reduced Damage Accrual in Systemic Lupus Erythematosus
2016
·
M.W.P. Tsang-A-Sjoe
, I.E.M. Bultink
, et al.
·
Annals of the Rheumatic Diseases
·
1
OP0314 Is Cardiovascular Risk Management in Patients with Rheumatoid Arthritis Effective? Two Year Follow Up Reveals Unexpected Rise in Cardiovascular Risk!
2015
·
M. Heslinga
, I. van den Oever
, et al.
·
Annals of the Rheumatic Diseases
·
1
Cardiovascular risk in Rheumatoid Arthritis and other inflammatory disorders: Clinical management and interventional aspects
2021
·
Maaike Heslinga
·
Pure Amsterdam UMC
Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity
2021
·
Maaike Heslinga
, Gilles Lambert
, et al.
·
Rheumatology
Show more works
View as search
Works count:
33
Citation count:
2,163
H-index:
10
I10-index:
10
Year
Topic
Type
